Healthcare -
Biotechnology - NASDAQ - US
$ 0.3401
-5.11 %
$ 3.83 M
Market Cap
-0.01
P/E
CYCC - STOCK-BASED COMPENSATION
Stock-based Compensation CYCC - Cyclacel Pharmaceuticals, Inc.
1.47 M
LAST VALUE
12.83%
2 YEAR CAGR
34.80%
5 YEAR CAGR
15.23%
10 YEAR CAGR